SCHEMBL4789079

SCHEMBL4789079

CC(C)N1CCNC(C(=O)N2CCN(c3ccc(F)cc3)CC2)C1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 5/20 0.53
CCR5 P51681 1/20 0.53
KCNH2 Q12809 1/20 0.53
CYP1A2 P05177 1/20 0.51
USP2 O75604 1/20 0.46
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46
DPP4 P27487 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
PANK3 Q9H999 1/20 0.44
MAPT P10636 1/20 0.43
RECQL P46063 1/20 0.43
AKR1C3 P42330 1/20 0.43
GFER P55789 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1778289 1.00 CCR2 (0.53) CCR2CCR5KCNH2CYP1A2USP2
SCHEMBL1781132 0.89 CCR2 (0.54) CCR2CCR5KCNH2CYP1A2MAPK1
SCHEMBL28776156 0.88 CCR2 (0.59) CCR2CCR5KCNH2SMN1; SMN2DPP4
SCHEMBL1779318 0.88 CCR2 (0.59) CCR2CCR5KCNH2SMN1; SMN2DPP4
SCHEMBL1777343 0.88 CCR2 (0.55) CCR2CCR5KCNH2USP2MAPK1
SCHEMBL27741680 0.88 CCR2 (0.55) CCR2CCR5KCNH2USP2MAPK1
SCHEMBL1778136 0.88 CCR2 (0.53) CCR2CCR5KCNH2CYP1A2
SCHEMBL1779272 0.88 CCR2 (0.51) CCR2CCR5KCNH2SMN1; SMN2HRH3
SCHEMBL1778328 0.86 CCR2 (0.52) CCR2CCR5KCNH2CYP1A2USP2
SCHEMBL1778450 0.86 CCR2 (0.52) CCR2CCR5KCNH2CYP1A2USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101384582-A Piperazine compounds useful as antagonists of C-C chemokines (CCR2B and CCR5) for the treatment of inflammatory diseases ASTRAZENECA AB (SE) 2009-03-11 CN disclosed
EP-1966187-A1 PIPERAZINE COMPOUNDS USEFUL AS ANTAGONISTS OF C-C CHEMOKINES (CCR2B AND CCR5) FOR THE TREATMENT OF INFLAMMATORY DISEASES AstraZeneca AB (SE) 2008-09-10 EP disclosed
WO-2007071952-A1 PIPERAZINE COMPOUNDS USEFUL AS ANTAGONISTS OF C-C CHEMOKINES (CCR2B AND CCR5) FOR THE TREATMENT OF INFLAMMATORY DISEASES ASTRAZENECA AB (SE) 2007-06-28 WO disclosed